The "atypical antipsychotic" group of drugs used to treat children with aggression and schizophrenia could increase the risk of developing Type 2 diabetes and heart disease, researchers from the Johns Hopkins Children's Center in Baltimore, USA, have claimed.
Register Now to Continue Reading
Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:
What's Included
-
Free access to 4 subscriber-only articles per month
-
Email newsletter providing advice and guidance across the sector
Already have an account? Sign in here
